Psychiatry AtlasMedication guide · United States

Medicine that supports alcohol abstinence

Disulfiram (Antabuse)

Generic name
disulfiram
Brand names
Antabuse
Medication class
Medicine that supports alcohol abstinence
Forms covered
Disulfiram oral tablets

Article updated: 2026-10-24 · Sources last checked: 2026-11-05

Medication Safety Alerts

FDA Boxed Warning

Alvogen disulfiram 250 mg oral tablets, ANDA091681.

Disulfiram must never be given during alcohol intoxication or without the person’s full knowledge. The prescriber must explain these restrictions to relatives and caregivers.

Disulfiram supports alcohol abstinence by causing a potentially dangerous reaction with alcohol. Informed consent, alcohol avoidance and liver monitoring are essential.

Antabuse (historical brand).

What to expect: Disulfiram makes drinking alcohol potentially dangerous; it does not treat acute alcohol withdrawal or directly remove every craving.

Warning signs
Sources last checked:
2026-11-05

What is this medicine used for?

FDA-approved uses

  • Support of alcohol abstinence — Selected adults who understand and agree to treatment. Adjunct to supportive care; not acute withdrawal treatment.Disulfiram oral tablets.

What should I expect?

Disulfiram makes drinking alcohol potentially dangerous; it does not treat acute alcohol withdrawal or directly remove every craving. It works within an agreed abstinence plan with ongoing support.

Follow-up should address whether the plan is helping and whether side effects, alcohol exposure or liver symptoms have appeared. Never test its effect by drinking.

How do I take it safely?

Start only with a clinician’s plan after at least 12 hours without alcohol and no intoxication. The person must know and consent; it must never be secretly administered. Assessment also considers withdrawal, severe heart disease, psychosis and other contraindications.

Avoid alcohol in drinks and relevant medicines, foods or skin products throughout treatment and for up to 14 days after stopping. Do not perform a drinking test. Metronidazole and alcohol-containing products must not be combined; other interactions, including warfarin and phenytoin, need review.

Have liver tests before starting and again at approximately 10–14 days, with later monitoring as directed. Watch for new liver, nerve, vision or mental-health symptoms. Discuss pregnancy and breastfeeding; the label advises against breastfeeding.

For a missed dose, do not double. If you have consumed alcohol or may be intoxicated, contact the clinician before taking another tablet. Stopping should include follow-up for the abstinence plan.

Paraldehyde and allergy to thiuram compounds are additional reasons not to use disulfiram.

Do not use this product after a known allergy to its active medicine or ingredients; tell the pharmacist about previous medication reactions.

What side effects should I know about?

  • Drowsiness, fatigue, headache, metallic or garlic-like taste and skin eruptions.

Tell your prescriber about effects that are persistent, troublesome, or interfere with daily life.

Which warning signs need help?

  • The boxed warning prohibits use during alcohol intoxication or without the person’s knowledge. An alcohol reaction can be fatal and can still occur up to 14 days after the last dose.
  • Severe vomiting, chest pain, trouble breathing, fainting, confusion or seizures after alcohol exposure requires emergency care.
  • Contact the clinician promptly for jaundice, dark urine, marked fatigue, poor appetite, new numbness, visual changes or psychotic symptoms. Severe liver injury can occur even after months of treatment and without earlier abnormal tests.

What else should I know to stay safe?

  • A clinician must assess alcohol withdrawal and confirm at least 12 hours without alcohol and no intoxication before starting. Avoid alcohol in drinks, relevant medicines, foods and skin products; never test the reaction by drinking.
  • Do not combine with metronidazole, paraldehyde or alcohol-containing products. Severe heart disease, psychosis and thiuram or product allergy can rule out use; warfarin, phenytoin and other medicines need interaction review.
  • Check liver tests before treatment and again at approximately 10–14 days, with later monitoring as directed. Discuss pregnancy; the label advises against breastfeeding. Stopping needs continuing support for the abstinence plan.

Urgent help and crisis support · Emergency & Crisis Resources (US)

What can help day to day?

  • Hidden alcohol matters too: ask the pharmacist about liquid medicines, sauces and relevant skin products.
  • The alcohol reaction can still occur for up to two weeks after stopping. Skipping a tablet is not a safe way to plan a drink.

How does it work?

Disulfiram changes how the body breaks down alcohol. It blocks a processing step, allowing a substance called acetaldehyde to build up if alcohol is consumed. This can cause a very unpleasant and sometimes dangerous reaction, and anticipating that reaction can support a person’s decision not to drink.

Explore medication science

How was this medicine developed?

Antabuse received FDA approval in 1951. Disulfiram’s longstanding approach is to make alcohol exposure produce an unpleasant and potentially severe reaction; informed, voluntary treatment remains essential.

How do I say the name?

Disulfiram: dye-SUL-fi-ram. Capital letters show the stressed syllable.

Sources and References

Sources support the U.S. products described here. Product instructions can differ; use the information supplied with your own medicine.

  1. Disulfiram: current prescribing information — mechanism explanation

    Scope: Mechanism explanation only. Source sections checked: Clinical Pharmacology; Indications and Usage; Warnings: The Disulfiram-Alcohol Reaction..

  2. Disulfiram: FDA approval history
  3. Disulfiram: patient medicine information
  4. Disulfiram: Package Insert / Prescribing Information
  5. Naltrexone: prescribing information
  6. Disulfiram: verified neutral parent, PubChem CID 3117
  7. Incorporating Alcohol Pharmacotherapies Into Medical Practice: Chapter 3—Disulfiram — mechanism explanation

    Scope: Mechanism explanation only. Source sections checked: Pharmacology: Aversive treatment..

  8. NIMH: Understanding psychosis
  9. Frequently Asked Questions about Labeling for Prescription Medicines | FDA

Giving medicine safely to children: family guide (PDF, 3 pages)

How information is checked

Was this article helpful?

Was this article helpful?

Sends your choice, article identifier, edition and optional issue to Psychiatry Atlas. No name, email or medical details are requested. Daily network codes help prevent spam; hosting may process technical information. This is not a promise of anonymity. Privacy details.

Enable JavaScript to send feedback.

Suggest a missing topic or describe a correction. Please keep personal medical information out of website feedback.

Back to top